Fresenius SE & Co. KGaA
FRE
ISIN DE0005785604 / Valor 332902
Fresenius SE & Co. KGaA
UMushroom community rating:
About company
Fresenius SE & Co. KGaA is a global healthcare company with a focus on providing high-quality, affordable, and accessible treatment options to patients and healthcare providers. The company's Biopharma segment, represented by Fresenius Kabi, has a growing portfolio of biosimilars in the oncology and immunology fields, with recent approvals for products like Tyenne® and Idacio®. Additionally, Fresenius Helios is working on linking digitalization with its healthcare services, aiming to enhance clinical processes and decision-making through the use of artificial intelligence. With successful market entries worldwide, Fresenius SE & Co. KGaA is committed to advancing its growth strategy towards #FutureFresenius.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
31520 M
Market cap (USD)
886,266
Daily traded volume (Shares)
33.5 / 33.23
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Caterina F
Joseph WI Gospodinov
EQUITIES OF THE SAME SECTOR
